Trump 2.0 spells uncertainty for US healthcare, says analyst
A GlobalData analyst has warned that Trump's second term could see major changes in US healthcare, and RFK could rock the boat.
Corporate Governance
US maternal care failings due to ‘focus on reactive care’
FDA’s final rule on LDTs causes concern, but timeline looks unsteady
Reeves’ 2024 budget promises life sciences investment
US senators raise Pfizer and Eli Lilly telehealth prescribing concerns
As mpox spreads, ‘national governments have a moral responsibility to help’
What is mpox and how big of a threat is it?
‘Everyone is vulnerable’ – how climate change impacts human health
